Aller au contenu
Capteurs et mesuresArticle de recherche3 min read

Three smartwatches can detect atrial fibrillation, but accuracy differs by model

Collectif éditorial MoveVitals · Study published · Reading updated

Original paper:Smartwatch Electrocardiograms for Automated and Manual Diagnosis of Atrial Fibrillation: A Comparative Analysis of Three Models. · Frontiers in cardiovascular medicine · 2022 · Article original ↗

À retenir

In 100 patients in atrial fibrillation and 100 in sinus rhythm, Apple and Samsung watch algorithms diagnosed AF better than Withings (sensitivity/specificity 87%/86% and 88%/81% vs 78%/80%, p < 0.05), mainly because Withings gave more inconclusive ECGs. Expert reading ranked the watches differently, and the patients were recorded in a clinical setting.

Study design

Article de recherche

Reading basis

Published abstract

Reading focus

Design & applicability

Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.

Question de recherche

Smartwatches can record a single-lead ECG, but their built-in algorithms and the readability of their tracings may differ between models. The authors compared how well three commercial smartwatches detect atrial fibrillation (AF), both by automated algorithm and by expert reading.

Population et méthode

Prospective, non-randomized, adjudicator-blinded clinical study of 100 patients in AF and 100 in sinus rhythm; patients with atrial flutter were excluded. Each patient had 4 ECG recordings in random order: a conventional 12-lead ECG, an Apple Watch Series 5, a Samsung Galaxy Watch Active 3 and a Withings Move ECG. Every smartwatch ECG was analyzed by the watch's own proprietary software and by clinical experts, who also graded tracing quality.

Résultats

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Automated AF diagnosis was more accurate with Apple and Samsung than with Withings (sensitivity/specificity 87%/86% for Apple and 88%/81% for Samsung vs 78%/80% for Withings, p < 0.05), driven by more inconclusive ECGs with Withings.
  2. 2
    Expert interpretation was more accurate for Withings and Apple than for Samsung (sensitivity/specificity 96%/86% for Withings and 94%/84% for Apple vs 86%/76% for Samsung, p < 0.05).
  3. 3
    The Samsung gap was driven by more uninterpretable tracings: 15% versus 2% and 4% for the other two (p < 0.05).

Limites et incertitude

  1. 1
    Only 100 patients in AF and 100 in sinus rhythm, all recorded in a clinical setting, with atrial flutter excluded, so real-world use by people at home may perform differently.
  2. 2
    Only three models were tested; software and hardware versions change, so results may not hold for newer watches.
  3. 3
    The abstract does not say how inconclusive ECGs were counted in the accuracy figures beyond noting they reduced Withings' accuracy.
  4. 4
    This reading is based on the abstract only.

Mise en perspective

A smartwatch ECG can pick up atrial fibrillation, but which watch you have affects how often it gives an answer and how readable the trace is. A watch alert or recording is a prompt to see a clinician, not a diagnosis, and a normal result does not rule AF out.

Vos données

If your watch records ECGs, keep the recordings and note your symptoms, then share them with your clinician. Take recordings seated and still, the same way each time, and do not compare readings between different watch models.

Comprendre ce type de preuve

The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.

Résumé structuré des auteurs English

Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.

Aims

The diagnostic accuracy of proprietary smartwatch algorithms and the interpretability of smartwatch ECG tracings may differ between available models. We compared the diagnostic potential for detecting atrial fibrillation (AF) of three commercially available smartwatches.

Methods

We performed a prospective, non-randomized, and adjudicator-blinded clinical study of 100 patients in AF and 100 patients in sinus rhythm, patients with atrial flutter were excluded. All patients underwent 4 ECG recordings: a conventional 12-lead ECG, Apple Watch Series 5®, Samsung Galaxy Watch Active 3®, and Withings Move ECG® in random order. All smartwatch ECGs were analyzed using their respective automated proprietary software and by clinical experts who also graded the quality of the tracings.

Results

The accuracy of automated AF diagnoses by Apple and Samsung outperformed that of Withings, which was attributable to a higher proportion of inconclusive ECGs with the latter (sensitivity/specificity: 87%/86% and 88%/81% vs. 78%/80%, respectively, p < 0.05). Expert interpretation was more accurate for Withings and Apple than for Samsung (sensitivity/specificity: 96%/86% and 94%/84% vs. 86%/76%, p < 0.05), driven by the high proportion of uninterpretable tracings with the latter (2 and 4% vs. 15%, p < 0.05).

Conclusion

Diagnosing AF is possible using various smartwatch models. However, the diagnostic accuracy of their automated interpretations varies between models as does the quality of ECG tracings recorded for manual interpretation.

Sources et attribution

Smartwatch Electrocardiograms for Automated and Manual Diagnosis of Atrial Fibrillation: A Comparative Analysis of Three Models.

Abu-Alrub S, Strik M, Ramirez FD, Moussaoui N, Racine HP, Marchand H, Buliard S, Haïssaguerre M, Ploux S, Bordachar P.

Frontiers in cardiovascular medicine · 2022-02-04

DOI: 10.3389/fcvm.2022.836375 ↗PubMed · 35187135 ↗Europe PMC · Licence indiquée: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée

Sources vérifiées 2026-11-01

Guides pratiques

À lire ensemble

·Étude de cohorte

Activity–stroke and heart attack curves differ by accelerometer processing method

Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.

Preventive Medicine

Explications approfondiesLire l’étude →
·Validation : étude/revue

Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven

A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.

Forensic Science International

Explications approfondiesLire l’étude →
·Synthèse de revues

Activity trackers: about 1,800 more steps a day, but small effects on other outcomes

An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.

The Lancet Digital Health

Explications approfondiesLire l’étude →
·Validation : étude/revue

Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages

In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.

Sleep

Explications approfondiesLire l’étude →
Capteurs et mesures →